| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
University of Cambridge, Department of Clinical Biochemistry, Addenbrookes Hospital, Cambridge CB2 2QR, United Kingdom
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Cell Culture.
SCC9 cells were purchased from American Type Culture Collection
(9)
. HaCaT keratinocytes were a kind gift from Dr. R.
Fusenig (University of Ulm, Ulm, Germany; Ref. 10
).
Primary keratinocytes were propagated in keratinocyte serum-free medium
(Life Technologies, Inc., Paisley, United Kingdom). Cell lines were
maintained in either DMEM (HaCaT) or DME:F-12 (1:1; SCC) containing
10% FCS, 1 mg/ml each of penicillin and streptomycin, 1 mg/ml
glutamine, and 200 ng/ml hydrocortisone (all obtained from Sigma
Chemical Co., Poole, United Kingdom).
LSEs.
These were performed essentially as described by Prunieras et
al. (11)
. Briefly, epidermis was removed from human
skin after 710 days incubation at 37°C in
Ca2+- and Mg2+-free PBS.
The dermis was acellularized by 10 cycles of freeze thawing and seeded
with early-passage primary human keratinocytes and grown for 1014
days.
Probe Construction.
cDNA was oligo dT primed from 1 µg of total human keratinocyte RNA
and extended with SuperRT (HT Biotech, Cambridge, United Kingdom) as
standard. PCR was performed using SuperTaq polymerase (HT Biotech) with
the following primer pairs (all listed 5'- 3'-): Id-1,
CGCGAATTCGCCAAGAATCATGAAAG,
CGCTCTAGAGGCGCTTCAGCGACACA (EcoRI and
XbaI sites are underlined); Id-2,
ACAGCCTGTCGGACCACAGC, GCCTGCAAGGACAGGATGCT; Id-3,
GACGACATGAACCACTGCTA, TTGGAGATGACAAGTTCCGGAG; E2A,
ATCTACTCCCCGGATCACTC, TTCTCCTCCCGCTTGATCTC;
p21cip1waf1, AAGGTCAGTTCCTTGTGGAG,
ATTAGGGCTTCCTCTTGGAG; involucrin, CTCTGCCTCAGCCTTACTGT,
ATTCCCAGTTGCTCATCTCT; and ß-actin,
TACCTCATGAAGATCCTCAC, TTCGTGGATGCCACAGGACT (Eurogentec, Abingdon,
United Kingdom). PCR products were excised from 2% TAE agarose gels
and purified using GeneClean II (Bio101, St. Louis, MO) according to
the manufacturers recommendations. Probes were subsequently labeled
by multipriming (Amersham International, Buckinghamshire, United
Kingdom).
Northern Blotting.
RNA was prepared with TriReagent (Sigma) according to the
manufacturers recommendations. Five µg of total RNA were resolved
in 1.2% agarose gels in 0.5x TBE (45 mM Tris-borate, 1
mM EDTA) and transferred to Hybond N+ membranes
(Amersham) by capillary blotting. Nucleic acids were fixed by UV, and
hybridization was performed in Rapid Hybridization Buffer (Amersham)
for 2.5 h at 65°C prior to washes for 30 min at 65°C in each
of the following solutions: in 2x SSC (twice), 1x SSC, and 0.5x SSC
(all containing 0.1% SDS).
IHC.
Human face-lift skin was fixed overnight at 4°C in neutral buffered
formalin and embedded in paraffin wax. Five-µm sections were
deparaffinized, rehydrated, and then subjected to 10 min of high
temperature antigen retrieval by pressure cooking in 80 mM
sodium citrate. Sections were incubated in 3% hydrogen peroxide
solution for 30 min, followed by a 10% normal goat serum block.
Sections were incubated for 48 h at 4°C with one of the
following antibodies: polyclonal Id-1 (rabbit antimouse Id-1, residues
129148; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), used at 5
µg/ml; polyclonal Id-2 and Id-3 (rabbit antimouse, full-length, a
generous gift from Dr. Edward Prochownik, Department of
Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA), each
used at 5 µg/ml after an overnight preblock with BSA; monoclonal
E2A (antihuman E47, residues 195208; Santa Cruz) at 1
µg/ml; calcitonin (anti human; Europath, Bude, United Kingdom) at 5
µg/ml or involucrin (antihuman; Novocastra, Newcastle, United
Kingdom) at 1 µg/ml. Detection was with a biotinylated IgG (diluted
1:500 in 1% BSA/Tris buffered saline), streptavidin-conjugated
horseradish peroxidase and diaminobenzidine precipitation, followed by
hematoxylin counterstaining. Blocking of Id signals was performed using
a 10-fold excess by mass of the appropriate Id GST fusion peptides (a
kind gift from Edward Prochownik; data not shown). Immunoprecipitation
studies demonstrated low cross-reactivity between Id antibodies (data
not shown). Five hundred cells from three patients were counted per SCC
stage to quantify Id staining. ISH was performed according to the
method of Thomas et al. (12)
with the following
5'- and 3'-digoxygenin-labeled primers (listed 5'- 3'): Id-1
sense, CTCTACGACATGAACGGCTGCTACTC; Id-1, antisense,
GAGTAGCAGCCGTTCATGTCGTAGAG.
| Results |
|---|
|
|
|---|
|
|
Localization of Id and E-Proteins in Human Epidermis and in
LSEs.
To evaluate the pattern of HLH protein expression in human skin
in situ, sections were stained with a range of antibodies
(Fig. 2, CJ)
. We found cytoplasmic Id-1 localization in
the basal layers of the epidermis (Fig. 2, E and F)
, but some suprabasal nuclear staining was apparent in the
spinous and granular layers. Little staining was apparent in the
corneocytes. Id-2 staining was nuclear, and the basal layer appeared to
show the greatest levels of expression (Fig. 2G)
, with
down-regulation as cells transited to the stratum corneum. Subcellular
Id-3 localization was also nuclear and predominantly basal, although
some cells in the spinous layers also stained (Fig. 2H)
.
Interestingly, discrete columns of Id-2 and Id-3 staining cells
persisted throughout all of the suprabasal layers (Fig. 2, G and H
, arrows). Involucrin identifies the
granular and cornified layers (Fig. 2J)
, whereas nuclear
expression of the products of the E2A gene (E12 and/or E47)
was apparent throughout the epidermis (Fig. 2I)
.
The stratified organization of the LSE model closely resembles that of
human skin (Fig. 2, KO)
, and the pattern of Id staining
was qualitatively similar to that seen in normal skin.
Id Expression in SCC.
Sections from poorly (Fig. 3, AD)
, moderately (Fig. 3, EH)
, and
well-differentiated SCCs (Fig. 3, IL)
were stained for
Id-1, Id-2, and Id-3. In each case, Id-1 showed the abundant
cytoplasmic staining characteristic of basal keratinocytes, whereas
expression of Id-2 and Id-3 maintained a nuclear pattern. The
keratinized foci characteristic of well-differentiated SCCs displayed a
lack of Id staining, (Fig. 3, I, K, and L
, arrows).
The majority of malignant
keratinocytes in poorly differentiated SCC expressed Id-1 and Id-3
(Table 1)
with reduced staining in well-differentiated SCCs. Interestingly,
intermediate values were obtained in moderately differentiated SCCs.
Fewer cells expressed Id-2, and levels were similar in each stage.
|
|
| Discussion |
|---|
|
|
|---|
Differentiation of primary keratinocytes in response to calcium in vitro was marked by rapid Id mRNA down-regulation, consistent with cell cycle withdrawal and the onset of differentiation. Furthermore, the response of Id expression to mitogenic stimulation in serum-deprived HaCaT keratinocytes is consistent with a growth-promoting role. HaCaT cells undergo partial growth arrest in response to serum withdrawal and can be induced to re-enter the cell cycle in response to insulin and EGF, although entry into S-phase is delayed with the latter cytokine (2) . Insulin (acting via the insulin-like growth factor I receptor) stimulates similar Id induction to serum, whereas EGF alone shows a strong peak of Id message after 1 h but very little signal after 24 h, consistent with slower transit through the cell cycle. This suggests that EGF and insulin may, at least in part, exert their mitogenic effects through activation of Id expression.
HaCaT cells form a stratified epithelium in an organotypic coculture model (18) . However, attempts to block HaCaT differentiation in an analogous LSE model by ectopic Id expression were unsuccessful because we were unable to generate lines overexpressing Id-1, Id-2, or Id-3 (data not shown), indicating that Id expression can promote keratinocyte death under certain circumstances. Indeed, Norton et al. (4) reported that stable transfection of rat embryo fibroblast cells by Id vectors resulted in apoptosis.
In vivo, proliferation is a feature of transit amplifying cells in the basal layer of the epidermis, and cell cycle withdrawal and accumulation of differential markers are concomitant with migration to the spinous layer. We observed significant Id expression in the basal layer, consistent with proliferation, although staining persisted in a subset of keratinocytes in the spinous layer. This may represent either continued proliferation in the suprabasal compartment or postmitotic Id expression, a phenomenon reported in spermatogenesis (19) . Complete Id down-regulation was seen only prior to terminal differentiation and death, suggesting that Id proteins exert their influence at two discrete stages: in the promotion of proliferation and in the later regulation of terminal differentiation. Moreover, the transition of Id-1 from the cytoplasm of basal cells to the nucleus of spinous keratinocytes suggests a discrete mechanism of action. Unlike Id-1, Id-2 and Id-3 are known to be phosphorylated by cyclin E and cyclin A-cdk2 complexes in a cycle-dependent fashion, and sequestration of Id-1 in the cytoplasm may indicate an additional regulatory mechanism (4) . Indeed, contrasting subcellular Id localization was observed in intestinal crypt epithelia, chondrocytes, and in spermatogenesis (15 , 17 , 19) . Id proteins lack a nuclear localization sequence, and dimerization with E-proteins was shown to be a mechanism of nuclear translocation (20) . However, nuclear colocalization of E2A with Id-2 and Id-3 but not Id-1 in the basal layer was observed in our experiments. The Ids dimerize avidly with all E-proteins; hence, it is possible that an active mechanism sequesters Id-1 from E-proteins in the cytoplasm, preventing inappropriate transit to the nucleus (21) . This discrete pattern of Id localization may play a pivotal role in the homeostasis of the epidermis and other tissues.
Another novel observation was the columnar organization delineated by Id-2 and Id-3 expression. This suggests a complex architecture of epidermal organization and may be related to the epidermal proliferative unit as postulated by Potten (22) .
Transformed SCC9 and HaCaT keratinocytes undergo only very limited differentiation in culture, and this correlated with continued Id expression under conditions of high calcium and high cell densities, which may result from autocrine stimulation of the EGF receptor (14) . We reasoned that such Id dysregulation may be a feature of SCC in situ. SCC is thought to derive from a common compartment, the basal layer of the epidermis; however, different lesions were characterized by distinct levels of Id expression that correlated directly with disease course. In particular, poorly differentiated SCC exhibited the greatest Id immunoreactivity; such tumors have the greatest propensity to metastasize and hence, have the poorest prognosis. Lin et al. (16) reported a correlation between Id-1 expression and the aggressive phenotype of breast cancer cells, providing further evidence of an Id dosage effect in disease progression. However, we cannot exclude the possibility that Id expression reflects the stage of developmental arrest, and further analysis of the mechanisms of Id regulation in SCC is required. Id expression was absent from the foci of keratinized cells in well-differentiated SCC, and the association between decreased Id expression with the capacity for spontaneous differentiation provides further evidence that Id expression acts as a restriction point for keratinocyte maturation.
Although there is some redundancy in Id expression, their distinct expression profiles are indicative of discrete roles in epidermal maintenance. It is conceivable that the balance of Id proteins acts as a critical determinant in the creation of a permissive environment for keratinocyte maturation, perhaps via interaction with cell cycle components or regulation of an epidermis-specific class B HLH factor. Furthermore, we have evidence for at least two discrete modes of action, via regulation of proliferation and a later activity in the inhibition of terminal differentiation. The study of these mechanisms may provide much insight into the regulation of normal epidermal development and malignant transformation.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
1 Supported by a grant from Unilever Research. ![]()
2 To whom requests for reprints should be
addressed, at University of Cambridge, Department of Clinical
Biochemistry, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QR,
United Kingdom. Phone: 44-1223-336079; Fax: 44-1223-330598; E-mail: KL213{at}hermes.cam.ac.uk ![]()
3 The abbreviations used are: EGF, epidermal
growth factor; HLH, helix-loop-helix; LSE, living skin equivalent; IHC,
immunohistochemistry; ISH, in situ histochemistry; SCC,
squamous cell carcinoma. ![]()
Received 7/12/00. Accepted 9/13/00.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Tokuriki, T. Iyoda, K. Inaba, K. Ikuta, S. Fujimoto, M. Kumakiri, and Y. Yokota Dual role for Id2 in chemical carcinogen-induced skin tumorigenesis Carcinogenesis, September 1, 2009; 30(9): 1645 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ushio, T. Hashimoto, N. Kitamura, and T. Tanaka Id1 Is Down-Regulated by Hepatocyte Growth Factor via ERK-Dependent and ERK-Independent Signaling Pathways, Leading to Increased Expression of p16INK4a in Hepatoma Cells Mol. Cancer Res., July 1, 2009; 7(7): 1179 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kamalian, J. R. Gosney, S. S. Forootan, C. S. Foster, Z. Z. Bao, C. Beesley, and Y. Ke Increased Expression of Id Family Proteins in Small Cell Lung Cancer and its Prognostic Significance Clin. Cancer Res., April 15, 2008; 14(8): 2318 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-A. Zhang, Y. Hamajima, Q. Zhang, and J. Lin Identification of Id1 in Acquired Middle Ear Cholesteatoma Arch Otolaryngol Head Neck Surg, March 1, 2008; 134(3): 306 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tsunedomi, N. Iizuka, T. Tamesa, K. Sakamoto, T. Hamaguchi, H. Somura, M. Yamada, and M. Oka Decreased ID2 Promotes Metastatic Potentials of Hepatocellular Carcinoma by Altering Secretion of Vascular Endothelial Growth Factor Clin. Cancer Res., February 15, 2008; 14(4): 1025 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chaudhary, I. Sadler-Riggleman, J. M. Ague, and M. K. Skinner The Helix-Loop-Helix Inhibitor of Differentiation (ID) Proteins Induce Post-Mitotic Terminally Differentiated Sertoli Cells to Re-Enter the Cell Cycle and Proliferate Biol Reprod, May 1, 2005; 72(5): 1205 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kebebew, M. Peng, P. A. Treseler, O. H. Clark, Q.-Y. Duh, D. Ginzinger, and R. Miner Id1 Gene Expression Is Up-Regulated in Hyperplastic and Neoplastic Thyroid Tissue and Regulates Growth and Differentiation in Thyroid Cancer Cells J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6105 - 6111. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lofstedt, A. Jogi, M. Sigvardsson, K. Gradin, L. Poellinger, S. Pahlman, and H. Axelson Induction of ID2 Expression by Hypoxia-inducible Factor-1: A ROLE IN DEDIFFERENTIATION OF HYPOXIC NEUROBLASTOMA CELLS J. Biol. Chem., September 17, 2004; 279(38): 39223 - 39231. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Coppe, Y. Itahana, D. H. Moore, J. L. Bennington, and P.-Y. Desprez Id-1 and Id-2 Proteins as Molecular Markers for Human Prostate Cancer Progression Clin. Cancer Res., March 15, 2004; 10(6): 2044 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Murphy, L. B. Swigart, M. A. Israel, and G. I. Evan Id2 Is Dispensable for Myc-Induced Epidermal Neoplasia Mol. Cell. Biol., March 1, 2004; 24(5): 2083 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shan, M. Yu, C. Qiu, and E. G. Snyderwine Id4 Regulates Mammary Epithelial Cell Growth and Differentiation and Is Overexpressed in Rat Mammary Gland Carcinomas Am. J. Pathol., December 1, 2003; 163(6): 2495 - 2502. [Abstract] [Full Text] |
||||
![]() |
S. Fong, Y. Itahana, T. Sumida, J. Singh, J.-P. Coppe, Y. Liu, P. C. Richards, J. L. Bennington, N. M. Lee, R. J. Debs, et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis PNAS, November 11, 2003; 100(23): 13543 - 13548. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K.-W. Lee, K. Man, M.-T. Ling, X.-H. Wang, Y.-C. Wong, C.-M. Lo, R. T.-P. Poon, I. O.-L. Ng, and S.-T. Fan Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway Carcinogenesis, November 1, 2003; 24(11): 1729 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Siegel, W. Shu, and J. Massague Mad Upregulation and Id2 Repression Accompany Transforming Growth Factor (TGF)-{beta}-mediated Epithelial Cell Growth Suppression J. Biol. Chem., September 12, 2003; 278(37): 35444 - 35450. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tang, G. M. Gordon, M. G. Muller, M. Dahiya, and K. E. Foreman Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells J. Virol., May 15, 2003; 77(10): 5975 - 5984. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schindl, S. F. Schoppmann, T. Strobel, H. Heinzl, C. Leisser, R. Horvat, and P. Birner Level of Id-1 Protein Expression Correlates with Poor Differentiation, Enhanced Malignant Potential, and More Aggressive Clinical Behavior of Epithelial Ovarian Tumors Clin. Cancer Res., February 1, 2003; 9(2): 779 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. S. Ouyang, X. Wang, M.-T. Ling, H. L. Wong, S. W. Tsao, and Y.C. Wong Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16INK4a/pRB pathway Carcinogenesis, May 1, 2002; 23(5): 721 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Wilson, R. W. Deed, T. Inoue, M. Balzi, A. Becciolini, P. Faraoni, C. S. Potten, and J. D. Norton Expression of Id Helix-Loop-Helix Proteins in Colorectal Adenocarcinoma Correlates with p53 Expression and Mitotic Index Cancer Res., December 1, 2001; 61(24): 8803 - 8810. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schindl, G. Oberhuber, A. Obermair, S. F. Schoppmann, B. Karner, and P. Birner Overexpression of Id-1 Protein Is a Marker for Unfavorable Prognosis in Early-Stage Cervical Cancer Cancer Res., August 1, 2001; 61(15): 5703 - 5706. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |